The pharmaceutical world in 2026 is defined by a surge in "temperature-sensitive" medicine, ranging from mRNA vaccines to advanced cell and gene therapies. These high-value products require a level of thermal protection that traditional packaging cannot provide, especially during the "last mile" of delivery to remote clinics or home-based patients. The Unit Dose Packaging Market is meeting this...
Deutsch 
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt